BR102021007901A2 - formulação para enxaguante bucal com ação inibidora do vírus sars-cov-2 e redutora das patologias relacionadas - Google Patents

formulação para enxaguante bucal com ação inibidora do vírus sars-cov-2 e redutora das patologias relacionadas

Info

Publication number
BR102021007901A2
BR102021007901A2 BR102021007901A BR102021007901A BR102021007901A2 BR 102021007901 A2 BR102021007901 A2 BR 102021007901A2 BR 102021007901 A BR102021007901 A BR 102021007901A BR 102021007901 A BR102021007901 A BR 102021007901A BR 102021007901 A2 BR102021007901 A2 BR 102021007901A2
Authority
BR
Brazil
Prior art keywords
cov
sars
mouthwash
formulation
virus
Prior art date
Application number
BR102021007901A
Other languages
English (en)
Inventor
Tiaraju Elmano De Oliveira Ygurey
Original Assignee
Rubia Fernanda De Oliveira Munhoz
Tiaraju Elmano De Oliveira Ygurey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rubia Fernanda De Oliveira Munhoz, Tiaraju Elmano De Oliveira Ygurey filed Critical Rubia Fernanda De Oliveira Munhoz
Priority to BR102021007901A priority Critical patent/BR102021007901A2/pt
Publication of BR102021007901A2 publication Critical patent/BR102021007901A2/pt
Priority to PCT/BR2022/050137 priority patent/WO2022226613A1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A61Q11/02Preparations for deodorising, bleaching or disinfecting dentures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

formulação para enxaguante bucal com ação inibidora do vírus sars-cov-2 e redutora das patologias relacionadas. uma formulação para a obtenção de um produto inibidor do poder de transmissão do coronavírus, em especial o sars-cov-2, e redutor dos sintomas que afetam o corpo das pessoas infectadas e sua duração. a formulação contém uma mistura de componentes onde, em volume q.s.p 100 de uma base de água destilada, são adicionados: 0,2% de digluconato clorhexidina (clorexidina) e 0,2% de aroma de menta líquido (aromax menta líquido). a mistura do produto é realizada em equipamento misturador comum. o produto resultante é líquido, do tipo enxaguante bucal a ser utilizado especialmente por pessoas infectadas pelo coronavírus, em especial a cepa sars-cov-2. a utilização é feita com bochecho e gargarejo de alguns mililitros do produto, sendo um enxágue oral completo por 30 segundos duas vezes ao dia, tendo como resultado a redução da carga viral salivar da pessoa diagnosticada com covid-19 e a redução da duração e ação das patologias associadas ao vírus.
BR102021007901A 2021-04-26 2021-04-26 formulação para enxaguante bucal com ação inibidora do vírus sars-cov-2 e redutora das patologias relacionadas BR102021007901A2 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BR102021007901A BR102021007901A2 (pt) 2021-04-26 2021-04-26 formulação para enxaguante bucal com ação inibidora do vírus sars-cov-2 e redutora das patologias relacionadas
PCT/BR2022/050137 WO2022226613A1 (pt) 2021-04-26 2022-04-25 Formulação para enxaguante bucal com ação inibidora do vírus sars-cov-2 e redutora das patologias relacionadas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102021007901A BR102021007901A2 (pt) 2021-04-26 2021-04-26 formulação para enxaguante bucal com ação inibidora do vírus sars-cov-2 e redutora das patologias relacionadas

Publications (1)

Publication Number Publication Date
BR102021007901A2 true BR102021007901A2 (pt) 2021-08-03

Family

ID=77614876

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102021007901A BR102021007901A2 (pt) 2021-04-26 2021-04-26 formulação para enxaguante bucal com ação inibidora do vírus sars-cov-2 e redutora das patologias relacionadas

Country Status (2)

Country Link
BR (1) BR102021007901A2 (pt)
WO (1) WO2022226613A1 (pt)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI841252A (fi) * 1984-03-29 1985-09-30 Orion Yhtymae Oy Ny munvattenkomposition och foerfarande foer dess framstaellning.
WO2005084627A1 (en) * 2004-03-01 2005-09-15 University Of Iowa Research Foundation Alcohol-free chlorhexidine compositions

Also Published As

Publication number Publication date
WO2022226613A1 (pt) 2022-11-03

Similar Documents

Publication Publication Date Title
Li et al. Prevalence and severity of gingivitis in American adults.
BRPI0518866A2 (pt) composiÇço oral e mÉtodos de prevenir a formaÇço de placa e tÁrtaro, de promover ou manter a saéde sistÊmica em um humano e de tratar placa e cÁlculo em uma superfÍcie oral de um indivÍduo mamÍfero
BRPI0714417B8 (pt) método para fabricar uma composição de cuidado oral, de cuidado pessoal, limpadora e/ou de cuidado doméstico
ATE425732T1 (de) Formulierungen mit ceramiden und/oder pseudoceramiden und (alpha-)bisabolol zur behandlung von hautschaden
Vinod et al. A novel herbal formulation versus chlorhexidine mouthwash in efficacy against oral microflora
NO20052490D0 (no) Dagsdoseringsenheter for melatonin.
DK1341524T3 (da) Farmaceutisk præparat i form af en pasta omfattende en syre-labil aktiv bestanddel
AR026916A1 (es) Combinaciones farmaceuticas y su uso en el tratamiento de desordenes gastrointestinales
ATE216886T1 (de) Modulation der th1/th2 cytokinexpression durch ribavirin in aktivierten t-lymphozyten
HUP0400553A2 (hu) Gyógyászati készítmények
NO20073813L (no) Kladribinregime for behandling av multippel sklerose
BR102021007901A2 (pt) formulação para enxaguante bucal com ação inibidora do vírus sars-cov-2 e redutora das patologias relacionadas
BR0114296A (pt) Composição para branqueamento dos dentes e método para utilização de um agente branqueador ácido dicarboxìlico
DE602004016403D1 (de) Topische pharmazeutische Zusammensetzungen enthaltend aktive natürliche Bestandteile zur Verhütung und Behandlung von mucosalen Entzündungprozessen
BR102021007872A2 (pt) formulação para solução nasal com ação inibidora do vírus sars-cov-2 e das patologias relacionadas
EA200600471A1 (ru) Лечение устойчивости к аспирину с использованием radix salviae multiorrhizae, его экстракта и композиции
Di Domênico et al. Effectiveness of hydrogen peroxide as auxiliary treatment for COVID-19 hospitalized patients-preliminary results of a randomized double-blind clinical trial
HUP0303468A2 (hu) Egy vagy több shogaol alkalmazása afrodiziákumként
Mitra et al. Evaluation of the clinical efficacy of a herbal toothpaste in comparison with a triclosan containing toothpaste in a population of dental college students: A double-blind randomized controlled trial
NILES Winter eczema of the arms
KAZAMA et al. STUDIES ON THE INDUSTRIAL DENTAL HYGIENE (4) Observations of DMF by Wards and Suburban Area Tokyo City
Scimia et al. Functional evaluation of ultra-octogenarian patients undergoing Cardiac Rehabilitation: correlation between Six minute Walking Test and Rivermead Mobility Index
Bumbar RANGE OF PERIODONTAL TISSUE DISEASES IN PATIENTS WITH UROLITHIASIS
ES430307A1 (es) Un metodo para la preparacion de una formulacion inyectable de una sola fase.
Ghoshal et al. Irritant contact dermatitis from passive contact with sexual massage oils-'sexual contact dermatitis'.

Legal Events

Date Code Title Description
B03B Publication of an application: publication anticipated [chapter 3.2 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: YGUREY TIARAJU ELMANO DE OLIVEIRA (BR/SP) ; ERIC STERNBERG (BR/SP)